Overview
Amgen has acquired Dark Blue Therapeutics Ltd. for up to $840 million. This acquisition enhances Amgen's oncology portfolio and targets acute myeloid leukemia, addressing challenges of relapse and treatment resistance.
Products
Loading...
Recent Deals
Amgen has acquired Dark Blue Therapeutics Ltd. for up to $840 million. This acquisition enhances Amgen's oncology portfolio and targets acute myeloid leukemia, addressing challenges of relapse and treatment resistance.